Le Lézard
Classified in: Health, Science and technology

HELIX Life Sciences Launches a New Collaboration Platform and Brand Initiative

SAN FRANCISCO, July 13, 2018 /PRNewswire-PRWeb/ -- HELIX Life Sciences, a leading provider of life sciences collaboration solutions and services, today announced it has launched it's latest drug development collaboration platform, HELIX Coretm.

"We are very pleased to announce the launching of HELIX Core. HELIX Core is the culmination of years of experience with a broad spectrum of life sciences companies ? 12 Beta customers in total, all striving to bring innovations to their market in a more efficient and compliant way," said Amber Bahl, HELIX's CEO. "I'm extremely proud of the HELIX team we've assembled to spearhead this launch. These are seasoned life science and IT professionals, armed with proven processes, technical expertise and amazing insight into how the process of developing pharmaceutical products can be optimized via seamless and advanced collaboration," said Bahl.

HELIX Core empowers teams to closely and effectively collaborate on work items and documentation throughout the drug development cycle. Being purpose-built for life sciences teams, HELIX requires no upfront software development process and can be implemented in a matter of days.

"Our goal is to disrupt the current collaboration market with industry-specific applications ? solutions that offer comprehensive, out-of-the-box functionality at a fraction of the cost of conventional platforms offered by today's vendors," continued Bahl. "For Life Sciences organizations, HELIX represents a significantly faster, more economical way to empower their teams ? along with an increased ability to maintain compliance requirements across their parallel and complex projects."

HELIX is the latest company to be spun off by San Francisco's Cyclotron Group (http://www.cyclotrongroup.com) ?a global IT and technology development company focused on creating industry-specific collaboration empowerment solutions.

"We're also excited about launching HELIX's new brand initiative via our latest website," said Bahl. "We've gotten excellent feedback on the platform from our Beta users. They concur that our disruptive positioning in the marketplace is a more powerful, and significantly cheaper, way to foster accelerated drug development via cloud-based, purpose-built collaboration solutions," concluded Bahl.

About HELIX for Life Sciences
HELIX Life Sciences' focus is to create a new standard of drug development collaboration efficiency and compliance. HELIX Coretm ships with multiple modules all centered around collaboration for drug discovery and development. HELIX Core is the first component of the platform. Planned additions to HELIX include purpose-built modules for Commercial, QA, Clinical ? GxP, and Non-GxP. Headquartered in San Francisco, HELIX was founded in 2017, and currently has over 50 employees in the US and Asia. HELIX is a part of the Cyclotron Group of companies. For more information, visit the company's website at http://www.HelixLifeSciences.com


SOURCE HELIX for Life Sciences

These press releases may also interest you

at 09:00
Medical Marijuana, Inc. , the first-ever publicly traded cannabis company in the United States, today announced that its subsidiary Phyto Animal Health will be exhibiting its products and speaking on a featured expert panel at CBD Expo West in...

at 09:00
BRIDGEWATER, N.J., Sept. 18, 2018 /PRNewswire-PRWeb/ -- Several years ago, Steve and Jen Butwill left the comforts of suburban life in Bridgewater to establish a medical clinic in a remote area of Liberia, West Africa. The young couple willingly...

at 09:00
HOUSTON, Sept. 18, 2018 /PRNewswire-PRWeb/ -- Representatives with Houston-based Top Acupuncture announced today that it is now providing diabetes treatments at its local clinic. "Diabetes itself won't kill people, but its complications such as...

at 09:00
Postoperative Pain Management to Witness Surge in Demand Owing to Increasing Surgical Procedures and Rising Prevalence of Chronic Postoperative Pain and Neuropathic Pain ? Persistence Market Research The number of patients undergoing surgical...

at 09:00
Wamberg Genomic Advisors and National Benefit Partners (NBP) have partnered to distribute Wamberg's Cancer Guardiantm program as an employee benefit to leading employers nationwide. Cancer Guardian is a leading advancement in personalizing cancer...

at 09:00
Change Healthcare today announced the establishment of a new cloud-based network infrastructure to promote more efficient, transparent, and secure administrative and financial transactions. As the first stage of a collaborative initiative working...

News published on 13 july 2018 at 23:00 and distributed by: